Roche’s alzheimer’s drug clears plaques in 28 weeks, faces 2028 test to slow memory loss

Business News Nigeria 9 h Nigeria

Roche’s experimental Alzheimer’s drug, trontinemab, has cleared harmful protein deposits from the brains of nine out of 10 patients within read more Roche’s alzheimer’s drug clears plaques in 28 weeks, faces 2028 test to slow memory loss

Aggregated from the leading newsrooms of the country. Every story links to its original source.